The Clinical Research Team at MAPS conducts rigorous studies to evaluate the safety and efficacy of psychedelics, particularly MDMA, in therapeutic settings. Team members play various roles, from adherence raters to principal investigators, ensuring compliance with trial protocols, collecting data, and providing therapeutic support during treatment sessions. Their work advances scientific understanding of psychedelics, aiming to integrate these substances into mainstream mental health care.
Ana Koprivica
Adherence Rater
Audrey Redfield
Adherence Rater For Clinical T...
Christine Houghton
Independent Clinical Rater
Corinna Arriola Rios...
Adherence Rater
Dr. Rachel Turetzky ...
Adherence Rater
Myrriah Jannette Ph....
Adherence Rater
Peter Š.
Adherence Rater In Clinical Tr...
Renee R.
Adherence Rater
Rob Colbert Ma, Ph.D...
Co-therapist
Sean Christensen M.D...
Adherence Rater
View all